QuidelOrtho Corp (QDEL) earnings date
Feb 10, 2027, after close estimated
Estimated from the company's SEC filing cadence. The company has not confirmed it. Companies usually announce two to four weeks ahead.
- Fiscal period
- Q4 FY2026
- Confidence
- 52% chance of landing within a day
- Source
- Filing history on EDGAR
- Last checked
- 2026-11-19
Read by software from public filings and company announcements. Can be wrong. Verify with the company or the SEC. Not investment advice.
How this company behaves
| Announces its report date | Not enough announcements on file yet to say |
| Reports after the quarter ends | 38 days, typically, give or take 4 (last 8 releases) |
Last 8 releases
| Period | Released | Timing | Days after period end | Filing |
|---|---|---|---|---|
| Q3 FY2026 | Tue, Nov 3, 2026 | after close | 37 | 8-K |
| Q2 FY2026 | Thu, Aug 6, 2026 | after close | 39 | 8-K |
| Q1 FY2026 | Tue, May 5, 2026 | after close | 37 | 8-K |
| Q4 FY2025 | Wed, Feb 11, 2026 | after close | 45 | 8-K |
| Q3 FY2025 | Wed, Nov 5, 2025 | after close | 38 | 8-K |
| Q2 FY2025 | Tue, Aug 5, 2025 | after close | 37 | 8-K |
| Q1 FY2025 | Wed, May 7, 2025 | after close | 38 | 8-K |
| Q4 FY2024 | Wed, Feb 12, 2025 | after close | 45 | 8-K |
What they guided beta
| Q3 FY2026 | "Document Exhibit 99.1 QuidelOrtho Reports Third Quarter 2026 Financial Results ― Growth in Labs and Immunohematology Outside of China Highlights Underlying Business Strength ― ― New Cost Transformation and Enterprise Restructuring Program Expected to Deliver Over $80 Million in Annual Savings in 2027 ― ― Updated Full-Year 2026 Financial Guidance Narrowing Prior Ranges ― November 3, 2026 SAN DIEGO, CA November 3, 2026 — QuidelOrtho Corporation (Nasdaq: QDEL) (the “Company” or “QuidelOrtho”), a leading global provider of diagnostic solutions, today announced financial results for the third quart" exhibit |
| Q3 FY2026 | "The Company expects the program to deliver over $80 million in annual savings in 2027 and to record approximately $30 to $35 million in one-time restructuring charges in the fourth quarter of 2026." exhibit |
| Q3 FY2026 | "Full-year 2026 Financial Guidance Based on its current business outlook, the Company is updating its full-year financial guidance below: Full-year 2026 Financial Guidance As of 11/3/2026 As of 8/6/2026 Total revenues (reported) $2.52 - $2.54 billion $2.52 - $2.60 billion Adjusted EBITDA $540 - $545 million $540 - $560 million Adjusted EBITDA margin ~21% 21% - 22% Adjusted diluted EPS $0.65 - $0.70 $0.65 - $0.90 Please see page 8 of the Third Quarter 2026 Financial Results presentation on the “Investor Relations” page of the Company’s website for the full list of assumptions on which the Compan" exhibit |
| Q3 FY2026 | "These statements are any statement contained herein that is not strictly historical, including, but not limited to, QuidelOrtho’s commercial and other strategic goals, financial guidance for 2026 and related assumptions and other future financial condition and operating results, including growth expectations and expected results of operations, financial position or cost-savings and operational improvement initiatives, including the expected results and anticipated benefits of the cost transformation and enterprise restructuring program and the timing and amount of related charges, and other fu" exhibit |
| Q2 FY2026 | "Document Exhibit 99.1 QuidelOrtho Reports Second Quarter 2026 Financial Results ― Total revenue grew 3% reported and 2% constant currency, primarily driven by Labs and Point of Care growth― ― Excluding China, total revenue grew 6% both as reported and in constant currency ― ― Company updates full-year 2026 financial guidance ― August 6, 2026 SAN DIEGO, CA August 6, 2026 — QuidelOrtho Corporation (Nasdaq: QDEL) (the “Company” or “QuidelOrtho”), a leading global provider of diagnostic solutions, today announced financial results for the second quarter ended June 28, 2026." exhibit |
| Q2 FY2026 | "“As a result, we are revising our full-year 2026 revenue and earnings guidance to reflect these evolving market dynamics." exhibit |
| Q2 FY2026 | "Full-year 2026 Financial Guidance Based on its current business outlook, the Company is updating its full-year financial guidance below: Full-year 2026 Financial Guidance Updated (as of 8/6/2026) Previous (as of 5/5/2026) Total revenues (reported) $2.52 - $2.60 billion $2.70 - $2.75 billion Adjusted EBITDA $540 - $560 million $615 - $630 million Adjusted EBITDA margin 21% - 22% 23% Adjusted diluted EPS $0.65 - $0.90 $1.80 - $2.00 Free cash flow Withdrawn $100 - $120 million Please see page 8 of the Second Quarter 2026 Financial Results presentation on the “Investor Relations” page of the Compa" exhibit |
| Q2 FY2026 | "These statements are any statement contained herein that is not strictly historical, including, but not limited to, QuidelOrtho’s commercial and other strategic goals, financial guidance for 2026 and related assumptions and other future financial condition and operating results, including growth expectations and expected results of operations, financial position or cost-savings and operational improvement initiatives, and other future plans, objectives, strategies, expectations and intentions." exhibit |
Get this as JSON
curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/next/QDEL
# how far back the record goes for this company
curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/coverage/QDEL
Put this date on your page
A badge that stays current. It links back to this page and needs no key. Embed it unmodified, with its link to this page intact: the badge is too small to carry the notice below, so the page it links to does.
Read by software from public filings and company announcements. Can be wrong. Verify with the company or the SEC. Not investment advice.
HTML
<a href="https://veritasdata.dev/company/QDEL/"><img src="https://veritasdata.dev/embed/QDEL.svg" alt="QDEL earnings date" width="240" height="56"></a>
Markdown
[](https://veritasdata.dev/company/QDEL/)
Script
<script async src="https://veritasdata.dev/embed/QDEL.js"></script>
Get a free key: 100 calls, every company
Sign in with GitHub or Google. The key works on every endpoint and in the MCP server.
curl -H "X-API-Key: vt_live_..." "https://api.veritasdata.dev/v1/next/QDEL"
Dates come only from SEC EDGAR and company announcements. Nothing here is investment advice.